The risk of being unable to raise the additional funds needed for research and development and business continuity at the expected time, in the required amount, and on favorable terms. This covers the possibility that constraints on cash on hand or a deterioration in the financing environment for raising funds through shares, stock acquisition rights and other instruments could make it difficult to execute the research and development portfolio or investment plans.